A novel INPP4A mutation with pontocerebellar hypoplasia, myoclonic epilepsy, microcephaly, and severe developmental delay

Brain Dev. 2023 May;45(5):300-305. doi: 10.1016/j.braindev.2023.01.006. Epub 2023 Feb 8.

Abstract

Background: The inositol polyphosphate 4-phosphatase intracellular signaling pathway is susceptible to genetic or epigenetic alterations that may result in major neurological illnesses with clinically significant pons and cerebellum involvement.

Case reports: A seven-year-old girl with pontocerebellar hypoplasia, resistant myoclonic epilepsy with axial hypotonia, microcephaly, atypical facial appearance, nystagmus, ophthalmoplegia, hyperactive tendon reflexes, spasticity, clonus, extensor plantar response, contractures in wrists and ankles and growth retardation, whole-exome sequencing was performed and a homozygous "NM_001134225.2:c.646C > T, p.(Arg216Ter)" variant was found in the INPP4A gene.

Conclusion: INPP4A mutations should be kept in mind in cases with severely delayed psychomotor development, progressive microcephaly, resistant myoclonic epilepsy, isolated cerebellum, and pons involvement.

Keywords: Myoclonic seizures; Novel INPP4A mutation; Pontocerebellar hypoplasia; WES.

Publication types

  • Case Reports

MeSH terms

  • Cerebellar Diseases
  • Child
  • Epilepsies, Myoclonic*
  • Female
  • Humans
  • Microcephaly* / genetics
  • Mutation / genetics
  • Nervous System Malformations* / genetics
  • Olivopontocerebellar Atrophies* / genetics

Supplementary concepts

  • Pontocerebellar Hypoplasia